tetano
Editor, Senior Moderator
Respir Med Case Rep
. 2022;37:101663.
doi: 10.1016/j.rmcr.2022.101663. Epub 2022 May 6.
Spontaneous tension hemothorax in a severe COVID-19 patient receiving ECMO therapy: The other side of COVID-19-associated coagulopathy
Kanin Thammavaranucupt[SUP] 1 [/SUP], Tanapat Tassaneyasin[SUP] 1 [/SUP], Pongdhep Theerawit[SUP] 2 [/SUP], Yuda Sutherasan[SUP] 3 [/SUP], Pimwatana Pinsem[SUP] 4 [/SUP], Supawadee Suppadungsuk[SUP] 1 [/SUP], Nithita Nanthatanti[SUP] 1 [/SUP], Suppachok Kirdlarp[SUP] 1 [/SUP], Somnuek Sungkanuparph[SUP] 1 [/SUP], Sirawat Srichatrapimuk[SUP] 1 [/SUP]
Affiliations
Abstract
As opposed to widely recognized Coronavirus Disease 2019 (COVID-19)-associated thrombotic events, the unusual but serious bleeding complications in COVID-19 patients are worth-mentioned. Here, we describe a 44-year-old man afflicted by COVID-19 pneumonia with acute respiratory distress syndrome (ARDS) and submassive pulmonary embolism. The patient's condition initially improved with the prescription of ECMO, tocilizumab, and hemoadsorption, however, he later developed spontaneous tension hemothorax, which is considered rare but devastating in the setting of COVID-19. While the exact pathogenesis of COVID-19-associated bleeding events remains poorly understood, we aim to highlight the other aspect of coagulation dysfunction potentially caused by COVID-19.
Keywords: COVID-19; ECMO; Hemothorax; Pulmonary embolism.
. 2022;37:101663.
doi: 10.1016/j.rmcr.2022.101663. Epub 2022 May 6.
Spontaneous tension hemothorax in a severe COVID-19 patient receiving ECMO therapy: The other side of COVID-19-associated coagulopathy
Kanin Thammavaranucupt[SUP] 1 [/SUP], Tanapat Tassaneyasin[SUP] 1 [/SUP], Pongdhep Theerawit[SUP] 2 [/SUP], Yuda Sutherasan[SUP] 3 [/SUP], Pimwatana Pinsem[SUP] 4 [/SUP], Supawadee Suppadungsuk[SUP] 1 [/SUP], Nithita Nanthatanti[SUP] 1 [/SUP], Suppachok Kirdlarp[SUP] 1 [/SUP], Somnuek Sungkanuparph[SUP] 1 [/SUP], Sirawat Srichatrapimuk[SUP] 1 [/SUP]
Affiliations
- PMID: 35559365
- PMCID: PMC9072841
- DOI: 10.1016/j.rmcr.2022.101663
Abstract
As opposed to widely recognized Coronavirus Disease 2019 (COVID-19)-associated thrombotic events, the unusual but serious bleeding complications in COVID-19 patients are worth-mentioned. Here, we describe a 44-year-old man afflicted by COVID-19 pneumonia with acute respiratory distress syndrome (ARDS) and submassive pulmonary embolism. The patient's condition initially improved with the prescription of ECMO, tocilizumab, and hemoadsorption, however, he later developed spontaneous tension hemothorax, which is considered rare but devastating in the setting of COVID-19. While the exact pathogenesis of COVID-19-associated bleeding events remains poorly understood, we aim to highlight the other aspect of coagulation dysfunction potentially caused by COVID-19.
Keywords: COVID-19; ECMO; Hemothorax; Pulmonary embolism.